Literature DB >> 24115757

Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.

Gianluca Iacobellis1, Giorgio Barbarini, Claudio Letizia, Giuseppe Barbaro.   

Abstract

OBJECTIVE: Ectopic fat accumulation within the heart and the liver are linked to an increased cardiovascular risk. Ultrasound-measured cardiac and liver steatosis are easily accessible markers of intra-organ ectopic fat accumulation. The hypothesis that echocardiographic epicardial fat thickness is independently associated with nonalcoholic fatty liver disease (NAFLD) in obese subjects is tested. DESIGN AND METHODS: Sixty-two obese (BMI > 30 kg m⁻²) subjects with ultrasonographic evidence of NAFLD and 62 control obese subjects without history or signs of NAFLD underwent echocardiographic epicardial fat thickness measurement.
RESULTS: Epicardial fat thickness was significantly higher (P < 0.01) in obese subjects with NAFLD when compared to those without NAFLD. Epicardial fat thickness was significantly higher (9.7 ± 0.2 vs. 8 ± 0.7 mm, P < 0.01) in subjects with severe (ultrasound score 3) than those with moderate (score 2) liver steatosis. Among waist circumference and BMI, epicardial fat thickness resulted in the best independent correlate of liver steatosis (R²  = 0.77, P < 0.001).
CONCLUSIONS: Our study suggests that epicardial fat is a good predictor of liver steatosis in obese subjects. Echocardiographic epicardial fat predicts ultrasound-measured fatty liver better than BMI or waist circumferences does. Patients with severe fatty liver infiltration presented with the highest amount of cardiac fat accumulation.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24115757     DOI: 10.1002/oby.20624

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  23 in total

Review 1.  Local and systemic effects of the multifaceted epicardial adipose tissue depot.

Authors:  Gianluca Iacobellis
Journal:  Nat Rev Endocrinol       Date:  2015-04-07       Impact factor: 43.330

Review 2.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

3.  Characterization of mouse pericardial fat: regulation by PAPP-A.

Authors:  Laurie K Bale; Sally A West; Cheryl A Conover
Journal:  Growth Horm IGF Res       Date:  2018-07-11       Impact factor: 2.372

4.  Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients.

Authors:  Stefania Mariani; Daniela Fiore; Sabrina Basciani; Agnese Persichetti; Savina Contini; Carla Lubrano; Luisa Salvatori; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2014-10-31       Impact factor: 3.633

5.  Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Bin Liu; Yingrui Li; Yu Li; Yajie Liu; Yuling Yan; Aoran Luo; Hong Ren; Qiang She
Journal:  Hepatol Int       Date:  2019-08-20       Impact factor: 6.047

6.  Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men.

Authors:  Remzi Sarıkaya; Cihan Şengül; Ömer Kümet; Gürkan İmre; Tayyar Akbulut; Mustafa Oğuz
Journal:  Anatol J Cardiol       Date:  2022-02       Impact factor: 1.596

7.  Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study.

Authors:  Marcos M Lima-Martínez; Mariela Paoli; Marianela Rodney; Nathalie Balladares; Miguel Contreras; Luis D'Marco; Gianluca Iacobellis
Journal:  Endocrine       Date:  2015-08-02       Impact factor: 3.633

8.  Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.

Authors:  Sharon S Brouha; Phirum Nguyen; Ricki Bettencourt; Claude B Sirlin; Rohit Loomba
Journal:  Eur Radiol       Date:  2017-10-20       Impact factor: 5.315

Review 9.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

10.  Epicardial adipose tissue thickness and plasma homocysteine in patients with metabolic syndrome and normal coronary arteries.

Authors:  Akif Serhat Balcioğlu; Murtaza Emre Durakoğlugil; Davran Ciçek; Uğur Abbas Bal; Bülent Boyaci; Haldun Müderrisoğlu
Journal:  Diabetol Metab Syndr       Date:  2014-05-26       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.